Article
p53 mutations in chondrosarcoma.
Diagnostic molecular pathology : the American journal of surgical pathology, part B - 1 Feb 1998
Terek R M, Healey J H, Garin-Chesa P, Mak S, Huvos A, Albino A P
Abstract excerpt
Chondrosarcoma is a primary bone tumor that has several different grades and variants. We evaluated 48 chondrosarcomas for p53 overexpression and p53 mutations. p53 expression was evaluated with immunohistochemistry using monoclonal antibodies PAb421, PAb1801, and PAb240. p53 mutations were identified with single-strand conformational polymorphism (SSCP) and DNA sequencing in selected cases. Immunohistochemistry...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
